Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9BSB4
UPID:
ATGA1_HUMAN
Alternative names:
-
Alternative UPACC:
Q9BSB4; Q9HAE2; Q9HBN1
Background:
Autophagy-related protein 101 plays a pivotal role in cellular homeostasis by facilitating autophagosome formation. It achieves this by stabilizing ATG13, thereby preventing its degradation by the proteasome. This protein's function is crucial for the autophagy process, a cellular mechanism essential for the removal of damaged cellular components and pathogens.
Therapeutic significance:
Understanding the role of Autophagy-related protein 101 could open doors to potential therapeutic strategies. Its fundamental role in autophagy suggests that modulation of its activity could be beneficial in diseases where autophagy is dysregulated.